Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1991; Volume 40,Issue 5
  • You have access
    Alpha-naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor.
    T A Gasiewicz and G Rucci
    Molecular Pharmacology November 1991, 40 (5) 607-612;
  • You have access
    Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
    M L Handel, A deFazio, C K Watts, R O Day and R L Sutherland
    Molecular Pharmacology November 1991, 40 (5) 613-618;
  • You have access
    The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
    D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
    Molecular Pharmacology November 1991, 40 (5) 619-626;
  • You have access
    Molecular interaction of the human alpha 2-C10-adrenergic receptor, when expressed in Rat-1 fibroblasts, with multiple pertussis toxin-sensitive guanine nucleotide-binding proteins: studies with site-directed antisera.
    S J McClue and G Milligan
    Molecular Pharmacology November 1991, 40 (5) 627-632;
  • You have access
    Prostaglandin receptors in NIH 3T3 cells: coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C.
    F Gusovsky
    Molecular Pharmacology November 1991, 40 (5) 633-638;
  • You have access
    Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
    V Ramkumar, M E Olah, K A Jacobson and G L Stiles
    Molecular Pharmacology November 1991, 40 (5) 639-647;
  • You have access
    Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.
    H A Brown, E R Lazarowski, R C Boucher and T K Harden
    Molecular Pharmacology November 1991, 40 (5) 648-655;
  • You have access
    Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.
    B F Thomas, D R Compton, B R Martin and S F Semus
    Molecular Pharmacology November 1991, 40 (5) 656-665;
  • You have access
    High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
    R Haring, D E Pellegrini-Giampietro, S R Zukin, R S Zukin and M A Scheideler
    Molecular Pharmacology November 1991, 40 (5) 666-673;
  • You have access
    Ultraviolet photoproducts of tryptophan can act as dioxin agonists.
    W G Helferich and M S Denison
    Molecular Pharmacology November 1991, 40 (5) 674-678;
  • You have access
    Purification and characterization of human liver microsomal cytochrome P-450 2A6.
    C H Yun, T Shimada and F P Guengerich
    Molecular Pharmacology November 1991, 40 (5) 679-685;
  • You have access
    Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1.
    F De Matteis, S J Dawson, A R Boobis and A Comoglio
    Molecular Pharmacology November 1991, 40 (5) 686-691;
  • You have access
    Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung.
    M P Lawton, T Kronbach, E F Johnson and R M Philpot
    Molecular Pharmacology November 1991, 40 (5) 692-698;
  • You have access
    Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
    J F Riou, P Helissey, L Grondard and S Giorgi-Renault
    Molecular Pharmacology November 1991, 40 (5) 699-706;
  • You have access
    Multiple Gi protein subtypes regulate a single effector mechanism.
    M A Gerhardt and R R Neubig
    Molecular Pharmacology November 1991, 40 (5) 707-711;
  • You have access
    Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    C David and S Fuchs
    Molecular Pharmacology November 1991, 40 (5) 712-716;
  • You have access
    Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
    I R Siemens, H J Adler, K Addya, S J Mah and S J Fluharty
    Molecular Pharmacology November 1991, 40 (5) 717-726;
  • You have access
    Different modes of regulation for receptors activating phospholipase C in the rat pancreatoma cell line AR4-2J.
    F S Menniti, H Takemura, K G Oliver and J W Putney
    Molecular Pharmacology November 1991, 40 (5) 727-733;
  • You have access
    Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    W Zheng, D Rampe and D J Triggle
    Molecular Pharmacology November 1991, 40 (5) 734-741;
  • You have access
    omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15.
    J L Werth, L D Hirning and S A Thayer
    Molecular Pharmacology November 1991, 40 (5) 742-749;
  • You have access
    Ethaverine, a derivative of papaverine, inhibits cardiac L-type calcium channels.
    Y Wang and R L Rosenberg
    Molecular Pharmacology November 1991, 40 (5) 750-755;
  • You have access
    Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
    D S Ragsdale, T Scheuer and W A Catterall
    Molecular Pharmacology November 1991, 40 (5) 756-765;
  • You have access
    Negative modulation of the gamma-aminobutyric acid response by extracellular zinc.
    J J Celentano, M Gyenes, T T Gibbs and D H Farb
    Molecular Pharmacology November 1991, 40 (5) 766-773;
  • You have access
    Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines.
    K Williams, J L Hanna and P B Molinoff
    Molecular Pharmacology November 1991, 40 (5) 774-782;
  • You have access
    Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
    S J Wall, R P Yasuda, M Li and B B Wolfe
    Molecular Pharmacology November 1991, 40 (5) 783-789;
  • You have access
    Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
    E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
    Molecular Pharmacology November 1991, 40 (5) 790-797;
  • You have access
    Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
    D T Aftab, L M Ballas, C R Loomis and W N Hait
    Molecular Pharmacology November 1991, 40 (5) 798-805;
  • You have access
    Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
    K Chae, M K Gibson and K S Korach
    Molecular Pharmacology November 1991, 40 (5) 806-811;
  • You have access
    cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol.
    L E Nagy, I Diamond and A S Gordon
    Molecular Pharmacology November 1991, 40 (5) 812-817;
  • You have access
    Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
    P A Harper, C L Golas and A B Okey
    Molecular Pharmacology November 1991, 40 (5) 818-826;
  • You have access
    Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
    C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
    Molecular Pharmacology November 1991, 40 (5) 827-832;
  • You have access
    Prostaglandin H synthase: perturbation of the tyrosyl radical as a probe of anticyclooxygenase agents.
    R J Kulmacz, G Palmer and A L Tsai
    Molecular Pharmacology November 1991, 40 (5) 833-837;
  • You have access
    Metabolism and DNA interaction of 2',3'-didehydro-2',3'-dideoxythymidine in human bone marrow cells.
    Z Zhu, M J Hitchcock and J P Sommadossi
    Molecular Pharmacology November 1991, 40 (5) 838-845;
  • You have access
    Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
    V Fischer, J A Haar, L Greiner, R V Lloyd and R P Mason
    Molecular Pharmacology November 1991, 40 (5) 846-853;
  • You have access
    Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
    W W Li, J T Lin, B I Schweitzer and J R Bertino
    Molecular Pharmacology November 1991, 40 (5) 854-858;
  • You have access
    Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
    D C Eberhart, B Gemzik, M R Halvorson and A Parkinson
    Molecular Pharmacology November 1991, 40 (5) 859-867;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 40, Issue 5
1 Nov 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics